Whooping cough cases in the United States have reached 4,598 on a cumulative year-to-date basis, according to provisional federal surveillance data, as kindergarten vaccination coverage for DTaP and other routine childhood shots has slipped to roughly 93 percent nationally. The uptick in pertussis follows years of pandemic-era suppression and arrives alongside a steady climb in school-entry vaccine exemptions, now estimated at 3.3 percent nationally, with multiple states exceeding 5 percent. The convergence of rising exemptions and returning disease transmission creates direct exposure risks for infants and young children who have not yet completed their full vaccine series.
Why 4,598 pertussis cases and falling DTaP coverage collide
Pertussis, the bacterial infection behind whooping cough, circulates in roughly cyclical patterns, with the most recent national peak recorded in 2012. After COVID-19 lockdowns and social distancing drove case counts to historic lows, CDC surveillance data show the disease returning toward pre-pandemic patterns. That rebound is happening while the population-level shield against the disease has weakened. A peer-reviewed CDC analysis of 2023–24 school year data found that coverage with MMR, DTaP, polio, and varicella vaccines among kindergartners stood at approximately 93 percent, with the national exemption estimate reaching 3.3 percent and exemptions exceeding 5 percent in multiple jurisdictions; those figures come from a recent kindergarten coverage report published in MMWR.
The practical consequence is straightforward. When a larger share of school-age children enter classrooms without DTaP protection, each pertussis introduction has more opportunity to spread. Infants younger than two months, who cannot yet receive their first dose, depend almost entirely on the immunity of older children and adults around them. A 93 percent coverage rate still falls short of the roughly 95 percent threshold that many epidemiologists consider necessary to limit sustained transmission of highly contagious respiratory pathogens. Even small gaps in coverage can create vulnerable clusters, especially in schools or communities where exemptions are concentrated rather than evenly distributed.
A testable question follows from these parallel trends: do states where kindergarten exemption rates exceed 5 percent account for a disproportionate share of 2024 pertussis cases per capita compared to states with lower exemption rates? The data needed to answer that question exist in two CDC datasets, the National Notifiable Diseases Surveillance System weekly tables and the SchoolVaxView kindergarten coverage dataset, but no published cross-tabulation has yet linked them at the jurisdiction level for the current reporting period. Analysts can already download state-level exemption figures from the public SchoolVaxView portal, but the absence of an official synthesis means that any correlation between exemptions and pertussis incidence remains an open research question rather than a settled conclusion.
CDC data, case definitions, and what the 4,598 figure includes
The 4,598 cumulative total is drawn from the National Notifiable Diseases Surveillance System (NNDSS), the federal system through which state and territorial health departments report notifiable diseases on a weekly basis. CDC has emphasized that these figures are preliminary and subject to reconciliation with jurisdictions before they become final annual totals. Delays in reporting, reclassification of probable cases, and removal of duplicates can all shift the numbers by the time year-end summaries are published. The agency makes the underlying records available through its open data portal, where researchers and the public can track weekly pertussis counts by state and compare them to prior years.
What counts as a reportable pertussis case is governed by the 2020 pertussis case definition, which requires either laboratory confirmation, typically through polymerase chain reaction testing, or an acute cough illness meeting strict clinical criteria such as paroxysmal coughing, post-tussive vomiting, or inspiratory whoop lasting at least two weeks. The current criteria are detailed in CDC’s official case definition document, which also distinguishes between confirmed and probable cases. Variations in how aggressively different jurisdictions test and apply these criteria can affect case counts, making direct state-to-state comparisons more complex than raw numbers suggest. A state that encourages broad testing of prolonged cough illnesses, for example, may identify more laboratory-confirmed infections than one that reserves testing for hospitalized patients or outbreak investigations.
No CDC or HHS release has yet detailed the vaccination status of the 4,598 reported cases. Without that breakdown, it is not possible to determine how many infections occurred among unvaccinated children versus vaccinated individuals experiencing waning immunity, a known limitation of acellular pertussis vaccines. BMJ reporting has linked the broader pertussis resurgence directly to falling routine immunization rates across several states, but the absence of case-level vaccination data leaves the precise contribution of exemptions versus waning protection unresolved. It also complicates messaging: public health agencies must explain both that vaccinated people can still get pertussis, particularly years after their last dose, and that unvaccinated children remain at much higher risk of severe disease and hospitalization.
Gaps in the evidence and what parents should watch
Several pieces of the puzzle are still missing from the public record. First, no jurisdiction-level cross-tabulation of 2024 pertussis cases against 2023–24 kindergarten exemption rates has been published by CDC or any state health department. That analysis would be the clearest test of whether high-exemption states are bearing a larger per-capita burden of disease. Second, no state epidemiologists have issued public statements specifying whether the cases in their jurisdictions met the 2020 clinical or laboratory criteria, information that would help clarify whether increased testing or genuine transmission is driving the count upward. Third, the most recent annual pertussis surveillance summary available through CDC Stacks has not been updated to benchmark 2024 totals against the 2012 peak, leaving the historical comparison incomplete and limiting the ability of policymakers to judge how urgent the current increase may be.
For parents and caregivers, the practical takeaway is direct. The most effective step to reduce a child’s risk of pertussis remains staying on schedule with the DTaP series in infancy and early childhood, followed by the Tdap booster recommended for adolescents and certain adults. Pregnant people are typically advised to receive Tdap during each pregnancy so that protective antibodies can pass to the fetus before birth, offering a crucial layer of defense during the first weeks of life when infants are too young to be vaccinated. Families should also pay attention to school-entry requirements and exemption policies in their state, since higher local exemption rates can increase the likelihood that a pertussis case introduced into a classroom will spread.
At the same time, parents can reasonably expect more clarity from public health agencies as the year progresses. Publishing jurisdiction-level analyses that overlay pertussis incidence with kindergarten exemption data, along with transparent breakdowns of case vaccination status and severity, would help communities understand whether the current rise is being driven primarily by pockets of low coverage, by waning immunity among vaccinated adolescents and adults, or by changes in testing behavior. Until those details are available, the broad contours of the evidence still point in a consistent direction: where routine childhood vaccination rates slip and exemptions climb, highly contagious diseases like whooping cough find new openings, and the youngest children bear the greatest risk.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
